DA
Dr. Adil Ahmed Khan
All India Institute of Medical Sciences, Maulana Azad Medical College, All India Institute of Medical Sciences Rishikesh, Jamia Hamdard
Research areas: Medicine · Oncology · Glioma Diagnosis and Treatment · Head and Neck Cancer Studies · Ovarian cancer diagnosis and treatment
Employment
-
AIIMS Delhi SENIOR RESIDENT2025 - 2028
-
MAMC SENIOR RESIDENT2025 - 2025
-
AIIMS Rishikesh SENIOR RESIDENT2025 - 2025
Education
- 2022 - 2025
-
Jamia Hamdard MBBS2014 - 2019
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- Effect of radical (chemo)radiotherapy on cardiovascular autonomic function in patients with head and neck cancer: a prospective observational study Save
- Clinical Presentation and Treatment Outcome of Multicentric Glioblastomas: A Case Series Save
- Extramammary Paget’s Disease of Vulva: An Unusual Entity Save
- Marginal Shortening of Life Expectancy in Japan During COVID-19: A Low Pandemic Impact Country Due to Improved Health Infrastructure and Awareness Save
- The Initial Developments to Contain SARS-CoV-2 Spread and the Viability of the Virus on Different Surfaces and Environments Save
- COVID-19 Aftereffects (Long COVID) Associated with Wuhan, Delta, and Omicron Variants Reported in Japanese Hospitals Save
- Review of Two Cases of Borderline Phyllodes Tumor of the Breast with Metastasis Save
- 4th Serosurvey of Tamil Nadu: Infection and Vaccine Generated Hybrid Immunity Save
- COVID-19 in Karnataka: Rise of Omicron Save
- Prevalence and Pathogenicity of Omicron Varian Save
- Mild Nature of SARS-CoV-2 Breakthrough Infections in Healthcare Workers in India Save
- COVID-19 in India: Breakthrough Infections in Delta Wave Save
- The Omicron Wave in India, Mumbai, and Delhi: Prevalence and Pathogenicity Save
- The Omicron Variant: Prevalence, Transmissibility, and Pathogenicity Save
- Serosurvey of Haryana and Odisha: COVID-19 Hybrid Immunity Save
- 5th and 6th Sero Survey of Delhi: Vaccine Activated Antibodies Enhancement Save
- 4th National Sero Survey of India: Vaccine Generated Antibodies Enhancement Save